Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Nitric-oxide synthase, endothelial | Starlite/ChEMBL | References |
Mus musculus | nitric oxide synthase 2, inducible | Starlite/ChEMBL | References |
Rattus norvegicus | Nitric-oxide synthase, brain | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | methionine synthase reductase | 0.0056 | 0.1332 | 0.4367 |
Giardia lamblia | Hypothetical protein | 0.0081 | 0.254 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0091 | 0.3051 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0081 | 0.254 | 0.2328 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0091 | 0.3051 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0091 | 0.3051 | 0.3543 |
Leishmania major | p450 reductase, putative | 0.0091 | 0.3051 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0056 | 0.1332 | 0.1547 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.034 | 0.1114 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0091 | 0.3051 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.1491 | 0.5 |
Brugia malayi | hypothetical protein | 0.0036 | 0.034 | 0.0395 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.034 | 0.1114 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0091 | 0.3051 | 0.2853 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0045 | 0.0787 | 0.5281 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.3051 | 0.3543 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0091 | 0.3051 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0056 | 0.1332 | 0.4367 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0091 | 0.3051 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0205 | 0.8611 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.034 | 1 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0045 | 0.0787 | 0.2581 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0091 | 0.3051 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0081 | 0.254 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0046 | 0.0822 | 0.2693 |
Brugia malayi | flavodoxin family protein | 0.0091 | 0.3051 | 0.3543 |
Brugia malayi | flavodoxin family protein | 0.0035 | 0.0277 | 0.0321 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0071 | 0.2066 | 0.24 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0091 | 0.3051 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0091 | 0.3051 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0091 | 0.3051 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0091 | 0.3051 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0081 | 0.254 | 0.8326 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.1491 | 0.4887 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.1491 | 0.4887 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0091 | 0.3051 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0091 | 0.3051 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0071 | 0.2066 | 0.24 |
Chlamydia trachomatis | sulfite reductase | 0.0056 | 0.1332 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0091 | 0.3051 | 1 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0035 | 0.0277 | 0.0321 |
Leishmania major | cytochrome P450 reductase, putative | 0.0081 | 0.254 | 0.8159 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0056 | 0.1332 | 0.4367 |
Treponema pallidum | flavodoxin | 0.0035 | 0.0277 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.034 | 0.1114 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.034 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0091 | 0.3051 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.1491 | 0.4378 |
Trypanosoma cruzi | p450 reductase, putative | 0.0091 | 0.3051 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0056 | 0.1332 | 0.1547 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0045 | 0.0787 | 0.5281 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0091 | 0.3051 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.1491 | 0.4887 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.1491 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.034 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0091 | 0.3051 | 0.3543 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0205 | 0.8611 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.034 | 0.1114 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0091 | 0.3051 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.034 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.1491 | 0.4887 |
Trichomonas vaginalis | set domain proteins, putative | 0.0233 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.0277 | 0.0907 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 384 nM | Inhibition of rat recombinant nNOS expressed in Escherichia coli using L-arginine as substrate up to 180 seconds by hemoglobin capture assay | ChEMBL. | 23993333 |
Ki (binding) | = 10996 nM | Inhibition of mouse recombinant iNOS expressed in Escherichia coli using L-arginine as substrate up to 180 seconds by hemoglobin capture assay | ChEMBL. | 23993333 |
Ki (binding) | = 17673 nM | Inhibition of bovine recombinant eNOS expressed in Escherichia coli using L-arginine as substrate up to 180 seconds by hemoglobin capture assay | ChEMBL. | 23993333 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.